Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Akira Kaji is active.

Publication


Featured researches published by Akira Kaji.


Journal of Organic Chemistry | 2015

3-Fluoroazetidinecarboxylic Acids and trans,trans-3,4-Difluoroproline as Peptide Scaffolds: Inhibition of Pancreatic Cancer Cell Growth by a Fluoroazetidine Iminosugar

Zilei Liu; Sarah F. Jenkinson; Tom Vermaas; Isao Adachi; Mark R. Wormald; Yukako Hata; Yukiko Kurashima; Akira Kaji; Chu-Yi Yu; Atsushi Kato; George W. J. Fleet

Reverse aldol opening renders amides of 3-hydroxyazetidinecarboxylic acids (3-OH-Aze) unstable above pH 8. Aze, found in sugar beet, is mis-incorporated for proline in peptides in humans and is associated with multiple sclerosis and teratogenesis. Aze-containing peptides may be oxygenated by prolyl hydroxylases resulting in potential damage of the protein by a reverse aldol of the hydroxyazetidine; this, rather than changes in conformation, may account for the deleterious effects of Aze. This paper describes the synthesis of 3-fluoro-Aze amino acids as hydroxy-Aze analogues which are not susceptible to aldol cleavage. 4-(Azidomethyl)-3-fluoro-Aze and 3,4-difluoroproline are new peptide building blocks. trans,trans-2,4-Dihydroxy-3-fluoroazetidine, an iminosugar, inhibits the growth of pancreatic cancer cells to a similar degree as gemcitabine.


Chemical & Pharmaceutical Bulletin | 1994

Four New Metabolites of Aspergillus terreus.

Akira Kaji; Tomoki Iwata; Noriki Kiriyama; Shinya Wakusawa; Kenichi Miyamoto


Biological & Pharmaceutical Bulletin | 1998

Relationship between the Structure and Cytotoxic Activity of Asterriquinone, an Antitumor Metabolite of Aspergillus terreus, and Its Alkyl Ether Derivatives

Akira Kaji; Ryo Saito; Masaaki Nomura; Kenichi Miyamoto; Noriki Kiriyama


Chemical & Pharmaceutical Bulletin | 1998

Preparation and Structure-Activity Relationships of Novel Asterriquinone Derivatives

Akira Kaji; Kengo Kimura; Masanori Teranishi; Noriki Kiriyama; Masaaki Nomura; Kenichi Miyamoto


The Journal of Antibiotics | 1998

Studies on the cytotoxicity of asterriquinone derivatives.

Akira Kaji; Tomoki Iwata; Noriki Kiriyama; Masaaki Nomura; Ken-ichi Miyamoto


Chemical & Pharmaceutical Bulletin | 1999

Preparation and route of asterriquinone monoalkyl ether from asterriquinone diacetate by treatment with a mixture of alcohol and alkali, followed by acidification

Akira Kaji; Ryo Saito; Yukako Hata; Noriki Kiriyama


Toxicology in Vitro | 2006

Cytotoxic evaluation of cubic boron nitride in human origin cultured cells

Kenjiro Koga; Akira Kaji; Kenichi Hirosaki; Yukako Hata; Tsutomu Ogura; Osamu Fujishita; Kazuhiro Shintani


Chemical & Pharmaceutical Bulletin | 1995

PARTIAL DEACETYLATION OF ASTERRIQUINONE DIACETATE BY AQUEOUS SODIUM BICARBONATE IN PYRIDINE

Akira Kaji; Kengo Kimura; Tomoki Iwata; Noriki Kiriyama


Japanese Journal of Pharmaceutical Health Care and Sciences | 2006

Basic Study on Glycyrrhizin Rectum Formulations Aiming at Improving Bioavailability

Kenjiro Koga; Kumiko Takekoshi; Akira Kaji; Yukako Hata; Tsutomu Ogura; Osamu Fujishita


Archive | 2012

1-チオキソ-1,2,3,4-テトラヒドロ-β-カルボリン誘導体およびそれらを含有する抗がん剤

Atsushi Kato; 敦 加藤; Isao Adachi; 伊佐雄 足立; Naoki Toyooka; 尚樹 豊岡; Akira Kaji; 聡 鍛冶; Yukiko Kurashima; 由紀子 倉島; Yukako Hata; 友佳子 畑; Tsutomu Ogura; 勤 小倉

Collaboration


Dive into the Akira Kaji's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge